In This Article:
Over the last 7 days, the Canadian market has remained flat, but it is up 22% over the past year with earnings forecast to grow by 16% annually. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. These smaller or newer companies can offer great value when built on solid financials, and we've identified three examples that combine balance sheet strength with potential for growth.
Top 10 Penny Stocks In Canada
Name | Share Price | Market Cap | Financial Health Rating |
Alvopetro Energy (TSXV:ALV) | CA$4.64 | CA$173.17M | ★★★★★★ |
Amerigo Resources (TSX:ARG) | CA$1.73 | CA$286.83M | ★★★★★☆ |
Pulse Seismic (TSX:PSD) | CA$2.30 | CA$116.04M | ★★★★★★ |
PetroTal (TSX:TAL) | CA$0.63 | CA$584.01M | ★★★★★★ |
Mandalay Resources (TSX:MND) | CA$3.38 | CA$325.16M | ★★★★★★ |
Winshear Gold (TSXV:WINS) | CA$0.16 | CA$5.03M | ★★★★★★ |
Findev (TSXV:FDI) | CA$0.45 | CA$12.75M | ★★★★★☆ |
Foraco International (TSX:FAR) | CA$2.10 | CA$207.81M | ★★★★★☆ |
NamSys (TSXV:CTZ) | CA$1.09 | CA$29.28M | ★★★★★★ |
East West Petroleum (TSXV:EW) | CA$0.04 | CA$3.62M | ★★★★★★ |
Click here to see the full list of 966 stocks from our TSX Penny Stocks screener.
Let's explore several standout options from the results in the screener.
NetraMark Holdings
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada, with a market cap of CA$38.12 million.
Operations: The company generates revenue from its healthcare software segment, totaling CA$0.35 million.
Market Cap: CA$38.12M
NetraMark Holdings, with a market cap of CA$38.12 million, is a pre-revenue company in the AI and machine learning space for pharmaceuticals, generating CA$0.35 million from its healthcare software segment. Recent board changes include the appointment of P.J. Haley, bringing significant commercial expertise from Exelixis Inc., which may enhance strategic growth initiatives. The company has expanded its product suite to improve clinical trial outcomes and market access strategies, though it remains unprofitable with increasing losses over five years and less than one year of cash runway despite no long-term liabilities or debt.
Amerigo Resources
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Amerigo Resources Ltd., with a market cap of CA$286.83 million, operates through its subsidiary Minera Valle Central S.A. to produce and sell copper and molybdenum concentrates from Codelco’s El Teniente underground mine in Chile.